WABC:NASDAQWestamerica Bancorporation Analysis
Data as of 2026-05-10 - not real-time
$54.85
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $54.85, comfortably above the 20‑day SMA (54.34) and the 50‑day SMA (52.47), with the 200‑day SMA (49.89) also below, indicating a clear bullish trend. RSI sits at 59.7, well under the overbought threshold, while beta of 0.61 suggests the share is less volatile than the broader market. Volume has been decreasing, yet price remains within a tight range bounded by support at $51.18 and resistance at $56.22, and the market sentiment index reads “Extreme Greed” at 90.73, reflecting strong investor optimism. Technical signals are mixed – the MACD histogram is slightly negative, hinting at short‑term pressure, but the overall moving‑average alignment and price momentum remain positive.
Recent earnings released for Q1 2026 show net income of $27.4 million with EPS of $1.13, and the board raised the quarterly dividend to $0.48 per share, a 4% increase. The company boasts a solid PE ratio of 12.2 versus an industry average of 16.4, a dividend yield of 3.39% with a 41% payout ratio, ample cash on hand, and a net‑cash position after debt. Analysts’ target price of $58 implies roughly a 5.7% upside, and the firm has announced an expanded share‑repurchase program, further supporting the valuation case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish SMA alignment with price above key moving averages
- Recent earnings beat and dividend increase
- Slight bearish MACD histogram suggesting short‑term caution
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued PE relative to industry peers
- Attractive dividend yield and sustainable payout
- Analyst target price indicating ~5‑6% upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong capital position with net cash and low leverage
- Consistent dividend growth and share‑repurchase program
- Low beta and defensive positioning in a regional banking niche
Key Metrics & Analysis
Financial Health
Revenue Growth-6.70%
Profit Margin44.30%
P/E Ratio12.2
ROE12.46%
ROA1.90%
P/B Ratio1.5
Industry P/E16.4
Technical Analysis
TrendBullish
RSI59.7
Support$51.18
Resistance$56.22
MA 20$54.34
MA 50$52.47
MA 200$49.89
MACDBearish
VolumeDecreasing
Fear & Greed Index90.73
Valuation
Target Price$58.00
Upside/Downside5.74%
GradeUndervalued
TypeValue
Dividend Yield3.39%
Risk Assessment
Beta0.61
Volatility14.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.